BDNF and neurodegenerative disease: More recently, fingolimod was shown to increase brain-derived neurotrophic factor (BDNF) mRNA and protein levels in mouse models of different neurological or neurodegenerative diseases in the cortex, hippocampus, and striatum [8,9,10,11].